title: [Cyclosporine A in the treatment of autoimmune hepatitis in the child: a case report].
abstract: The current immunosuppressive treatment of patients with autoimmune hepatitis consists of prednisone and azathioprine. High doses of prednisone used to obtain the remission of the disease are associated with serious adverse effects. To avoid harmful consequences of prednisone, we proposed to treat patients with oral cyclosporine to obtain the remission of the inflammatory process.
  
  
  CONCLUSIONS
  This case and review of the cases in the literature show that cyclosporine can induce remission of liver disease in children with autoimmune hepatitis, with few and well tolerated adverse effects.
authors.affiliation: Service de pédiatrie CHU Hédi Chaker Sfax.
authors.forename: Nabil
authors.initials: N
authors.lastname: Ben Halima
authors.forename: Melek
authors.initials: M
authors.lastname: Chaabouni
authors.forename: Abderrahmen
authors.initials: A
authors.lastname: Karray
authors.forename: Anas
authors.initials: A
authors.lastname: Krichen
authors.forename: Hatem
authors.initials: H
authors.lastname: Masmoudi
authors.forename: Rachid
authors.initials: R
authors.lastname: Jlidi
authors.forename: Ali
authors.initials: A
authors.lastname: Triki
mesh_terms: D000293:Adolescent; D016572:Cyclosporine / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D019693:Hepatitis, Autoimmune / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine